"Super testing" conducted early in this year's Arlington Park meet resulted in 26 positives for prednisone but found no evidence of other prohibited substances, according to the Illinois Racing Board.
Therapeutic medications will be the focus of the next round of "Super-Testing," the results of which should be available the first week of December during the University of Arizona Symposium on Racing. More than 500 blind samples remain to be tested for Class 4 medications.
More than 700 samples have been reviewed through the National Thoroughbred Racing Association's "super testing" program, with another 1,100 on the way before an Aug. 1 deadline. But in the absence of national equine medication rules, the "calling of positives" will depend upon the jurisdiction.
In a letter to the National Thoroughbred Racing Association, a group of chemists and veterinarians who form the Testing Integrity Program has warned that "super testing," as it is called, could create a public relations nightmare for the racing industry should the betting public believe use of illegal medications is rampant.
Most Popular Stories
- Close Hatches Dominates Personal Ensign
- Big Three Clash in Rich Travers Stakes
- California Chrome Sharpens Up at Los Alamitos
- Mark Valeski, Magna Graduate to Woodford
- Bayern Gallops 1 1/2 Miles On Eve of Travers
- Hootenanny, The Wow Signal to Meet in France
- Irish Surf Opts for Classic Over Del Mar 'Cap
- Chrome Set for Pennsylvania Derby Return
- Jerkens, Lukas, Durkin Honored at Saratoga
- Narniyn Seeks Breakthrough in Jean Romanet